Advancements in Plant-Based Antimicrobial Therapies Targeting Gram-Negative and Gram-Positive Bacterial Pathogens

Introduction

Plant-based antimicrobial therapies have garnered increasing attention as a viable solution to the global challenge of bacterial infections, particularly in the face of rising antibiotic resistance. Historically, medicinal plants have been a cornerstone of traditional medicine, offering a rich source of bioactive compounds with therapeutic properties. Unlike synthetic antibiotics, plant-derived substances often exhibit a broad spectrum of biological activities, including antibacterial, antiviral, antifungal, and anti-inflammatory effects [1]. The vast diversity of phytochemicals—such as alkaloids, flavonoids, phenolics, and terpenoids—makes them invaluable candidates for the development of novel antimicrobial agents. These natural compounds offer promising potential to combat both Gram-negative and Gram-positive bacteria, which differ significantly in their cell wall structures and resistance profiles.

Gram-positive bacteria, characterized by their thick peptidoglycan cell walls, include significant human pathogens like Staphylococcus aureus, Streptococcus pneumoniae, and Enterococcus faecalis. These organisms are responsible for a range of infections, from skin infections and pneumonia to more severe systemic diseases [2]. The growing prevalence of multidrug-resistant strains, such as methicillin-resistant Staphylococcus aureus (MRSA), poses a serious public health concern. Plant-based antimicrobials have shown efficacy against Gram-positive pathogens by mechanisms such as disrupting cell wall synthesis, inhibiting essential enzymes, and interfering with bacterial communication systems [3]. These multi-targeted actions make plant-derived compounds effective alternatives or adjuncts to traditional antibiotic therapies.

Gram-negative bacteria possess a more complex cell envelope, including an outer membrane rich in lipopolysaccharides, which acts as a barrier against many antimicrobial agents. Pathogens like Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae are notorious for their high resistance levels and involvement in severe infections, particularly in immunocompromised individuals [4]. The structural complexity of Gram-negative bacteria has limited the effectiveness of many conventional antibiotics. However, certain plant-based compounds have demonstrated the ability to permeabilize bacterial membranes, inhibit efflux pumps, and disrupt biofilm formation, thereby enhancing their antibacterial efficacy against Gram-negative strains [5]. These findings highlight the critical role of plant-derived antimicrobials in addressing the therapeutic gaps left by conventional treatments.

Recent advancements in extraction technologies have significantly improved the yield, purity, and efficacy of bioactive plant compounds. Techniques such as supercritical fluid extraction, ultrasonic-assisted extraction, and microwave-assisted extraction have enabled the efficient isolation of potent phytochemicals with minimal degradation [5-6]. Additionally, the integration of nanotechnology has revolutionized the delivery of plant-based antimicrobials. Nanocarriers such as liposomes, nanoparticles, and nanoemulsions enhance the solubility, stability, and bioavailability of these compounds, facilitating targeted delivery to infection sites and reducing potential toxicity. These technological innovations have broadened the scope of plant-based antimicrobials in both clinical and commercial applications.

The concept of synergistic therapy, combining plant-derived antimicrobials with conventional antibiotics, has opened new avenues for enhancing antibacterial efficacy and overcoming resistance. Studies have demonstrated that certain phytochemicals can restore the sensitivity of resistant bacterial strains to antibiotics by inhibiting resistance mechanisms such as β-lactamase activity and efflux pump function [7]. This combination approach not only maximizes therapeutic outcomes but also minimizes the required dosages of synthetic drugs, potentially reducing side effects and delaying the emergence of further resistance. Such synergistic strategies underscore the value of integrating plant-based compounds into existing antimicrobial regimens.

The exploration of plant-based antimicrobial therapies represents a promising and sustainable approach to addressing the global antibiotic resistance crisis. The unique chemical diversity and multi-targeted mechanisms of action of plant-derived compounds provide a versatile platform for developing new antibacterial agents [8]. The mechanisms of action, and clinical efficacy of these natural compounds is essential for translating laboratory findings into practical therapeutic applications. With advancements in biotechnology, pharmacology, and clinical research, plant-based antimicrobials are poised to play a pivotal role in the future landscape of infectious disease management.

Phytochemicals as Natural Antimicrobial Agents
Phytochemicals are naturally occurring bioactive compounds produced by plants as part of their defense mechanisms against pathogens, herbivores, and environmental stresses. These secondary metabolites include diverse chemical classes such as alkaloids, flavonoids, phenolic acids, terpenoids, saponins, and tannins, each known for unique antimicrobial properties. Alkaloids, for example, are nitrogen-containing compounds that disrupt microbial DNA replication and protein synthesis, while flavonoids interfere with bacterial membrane integrity and enzyme activity [9]. Phenolic compounds exert their antimicrobial effects by causing oxidative damage to bacterial cells and inhibiting quorum sensing, a key process in bacterial communication and biofilm formation. These multifaceted modes of action make phytochemicals effective against a wide range of bacterial pathogens, both Gram-positive and Gram-negative.

The ability of phytochemicals to target multiple bacterial structures and pathways significantly reduces the risk of resistance development, a critical advantage over conventional antibiotics that typically act on a single target. Furthermore, many plant-derived compounds exhibit synergistic effects when combined with other phytochemicals or antibiotics, enhancing their antibacterial efficacy. Recent studies have shown that essential oils, rich in terpenoids, can penetrate bacterial membranes, leading to cell lysis and death. Tannins, known for their protein-binding capabilities, can inhibit bacterial enzymes and disrupt cell wall integrity [10]. The broad-spectrum activity, coupled with their relatively low toxicity to human cells, positions phytochemicals as a promising foundation for the next generation of antimicrobial therapies.

2. Mechanisms of Action Against Gram-Positive Bacteria
Gram-positive bacteria, with their thick peptidoglycan cell walls, are particularly susceptible to agents that disrupt cell wall synthesis and integrity. Plant-based antimicrobials exploit this vulnerability through various mechanisms. For instance, certain flavonoids and phenolic acids can inhibit the enzymes involved in peptidoglycan biosynthesis, weakening the cell wall and leading to bacterial lysis. Some essential oils and terpenoids target the cytoplasmic membrane, increasing its permeability and causing leakage of vital cellular contents. Additionally, tannins and alkaloids interfere with critical metabolic processes, such as nucleic acid synthesis and protein folding, further impairing bacterial viability [11]. These multifactorial attack strategies make plant-based antimicrobials highly effective against Gram-positive pathogens, including resistant strains like MRSA.

The significant mechanism involves the disruption of quorum sensing, a bacterial communication system regulating gene expression, virulence factor production, and biofilm formation. Plant-derived compounds like coumarins and flavonoids have been shown to inhibit quorum sensing pathways in Gram-positive bacteria, thereby reducing their ability to form biofilms and express toxins. Biofilm inhibition is particularly important in clinical settings, where biofilm-associated infections are notoriously difficult to treat with conventional antibiotics. The capacity of plant-based antimicrobials to prevent biofilm formation not only enhances their therapeutic potential but also offers a preventive approach to infection control [12]. These insights highlight the versatility of plant-derived compounds in targeting Gram-positive bacterial infections.

3. Strategies to Combat Gram-Negative Bacterial Resistance
Gram-negative bacteria pose a significant therapeutic challenge due to their complex outer membrane, which acts as a barrier to many antibiotics and antimicrobial agents. Plant-based antimicrobials have shown promise in overcoming this barrier by disrupting membrane integrity and enhancing permeability. Compounds such as terpenoids and certain alkaloids have been documented to insert themselves into the lipid bilayer of Gram-negative bacteria, causing structural disruption and increased uptake of other antimicrobial agents, some phytochemicals inhibit the function of efflux pumps—protein complexes that bacteria use to expel toxic substances—thereby increasing the intracellular concentration of antimicrobial agents and enhancing their efficacy against resistant strains, plant-derived compounds target vital metabolic pathways within Gram-negative bacteria. Certain phenolic compounds and flavonoids interfere with energy production and enzyme activity, impairing bacterial growth and survival [13]. The inhibition of quorum sensing in Gram-negative bacteria by phytochemicals also reduces virulence factor production and biofilm formation, key contributors to antibiotic resistance. These multi-pronged strategies not only enhance the direct antibacterial action of plant-based compounds but also sensitize Gram-negative bacteria to conventional antibiotics, providing a dual mechanism for overcoming resistance. The growing body of evidence supporting these effects underscores the potential of plant-based antimicrobials in addressing the pressing issue of Gram-negative bacterial infections.

4. Advances in Extraction and Delivery Technologies
The efficacy of plant-based antimicrobials largely depends on the extraction methods used to isolate bioactive compounds. Traditional extraction techniques, while effective, often result in low yields or degradation of sensitive phytochemicals. Recent advancements in extraction technologies, such as supercritical fluid extraction, microwave-assisted extraction, and ultrasonic-assisted extraction, have revolutionized the field by improving yield, purity, and compound stability [14]. These modern techniques allow for the selective isolation of potent antimicrobial agents with minimal loss of bioactivity. For instance, supercritical CO₂ extraction enables the recovery of essential oils and terpenoids without the use of harmful solvents, preserving their antimicrobial properties and making them suitable for pharmaceutical applications.

The herapeutic potential of plant-based antimicrobials. Nanotechnology-based delivery platforms—such as liposomes, nanoemulsions, and polymeric nanoparticles—have been developed to improve the solubility, stability, and bioavailability of phytochemicals. These nanoformulations facilitate targeted delivery to infection sites, enhance penetration into bacterial biofilms, and reduce the required dosage, minimizing potential side effects [15]. Moreover, controlled release systems ensure sustained antimicrobial action, which is critical for effective treatment of chronic infections. Together, these technological advancements not only optimize the use of plant-derived antimicrobials but also open new avenues for their integration into mainstream medical and pharmaceutical applications.

5. Synergistic Effects with Conventional Antibiotics
One of the most promising applications of plant-based antimicrobials lies in their synergistic potential when combined with conventional antibiotics. Synergistic combinations can enhance antibacterial efficacy, restore the activity of antibiotics against resistant strains, and reduce the likelihood of resistance development. For example, certain flavonoids and phenolic acids have been shown to inhibit bacterial β-lactamases, enzymes that degrade β-lactam antibiotics like penicillin [16]. By blocking these resistance mechanisms, phytochemicals can restore the effectiveness of β-lactam antibiotics against resistant bacterial populations. Similarly, compounds like tannins and alkaloids can disrupt bacterial membranes, allowing greater penetration of antibiotics and enhancing their bactericidal effects.

The synergistic interaction between plant-based antimicrobials and antibiotics extends beyond enhancing efficacy—it also contributes to minimizing adverse effects associated with high antibiotic doses. By lowering the required concentration of antibiotics, combination therapies can reduce toxicity and side effects in patients. This approach also helps in preserving the efficacy of existing antibiotics by slowing the development of resistance. Clinical studies have demonstrated the success of such combinations in treating infections caused by multidrug-resistant bacteria, both Gram-positive and Gram-negative [17]. These findings underscore the importance of continued research into plant-antibiotic synergy as a strategic approach to combat antimicrobial resistance and improve therapeutic outcomes in infectious disease management.

6. Role of Essential Oils in Antibacterial Therapy
Essential oils, derived from aromatic plants, are complex mixtures of volatile compounds such as terpenes, terpenoids, and phenolic derivatives known for their potent antimicrobial properties. Their hydrophobic nature allows them to interact with and penetrate bacterial membranes, causing increased permeability, leakage of cellular contents, and eventual cell death. Essential oils like thymol, carvacrol, eugenol, and cinnamaldehyde have demonstrated significant antibacterial activity against a broad spectrum of pathogens [18]. These oils disrupt not only the structural integrity of bacterial membranes but also interfere with metabolic pathways, enzyme function, and genetic material, making them effective agents against both Gram-positive and Gram-negative bacteria.

The essential oils possess notable anti-biofilm properties, which is crucial since biofilm formation contributes to chronic infections and antibiotic resistance, quorum sensing and biofilm matrix formation, essential oils prevent bacterial colonization and persistence on surfaces. Their ability to synergize with conventional antibiotics further amplifies their therapeutic potential, especially in combating resistant bacterial strains. Due to their natural origin and broad-spectrum activity, essential oils are being explored not just in medicine but also in food preservation and agriculture as natural antimicrobial agents [19]. The challenge remains in standardizing dosages and minimizing cytotoxicity, which ongoing research and advanced delivery methods aim to address.

7. Tannins and Their Multifunctional Antibacterial Effects
Tannins, a group of high-molecular-weight polyphenols found abundantly in various plants, have shown significant antibacterial activity through multiple mechanisms. They exert their antimicrobial effect primarily by complexing with bacterial proteins, particularly enzymes, rendering them inactive and disrupting vital metabolic processes. Tannins can also precipitate microbial cell wall proteins, leading to increased cell permeability and structural damage [2]. This broad mechanism of action enables them to be effective against both Gram-positive and Gram-negative bacteria, making tannins a versatile antibacterial agent in plant-based therapies, tannins contribute to inhibiting bacterial adhesion to host tissues and surfaces, which is a critical initial step in infection and biofilm formation. By preventing bacterial attachment and interfering with communication signals such as quorum sensing, tannins reduce the pathogenic potential of bacteria. They have also been studied for their ability to chelate metal ions, depriving bacteria of essential nutrients required for growth. Tannins’ multifunctionality makes them attractive candidates for pharmaceutical applications, especially when formulated with other plant-based compounds or antibiotics for synergistic effects. Research continues to focus on optimizing their delivery and maximizing their efficacy in clinical settings.

8. Flavonoids as Broad-Spectrum Antimicrobial Agents
Flavonoids are a diverse class of polyphenolic compounds prevalent in fruits, vegetables, and medicinal plants, recognized for their wide-ranging biological activities, including antimicrobial properties. Their antibacterial action is attributed to several mechanisms, such as the inhibition of nucleic acid synthesis, disruption of cytoplasmic membranes, inhibition of energy metabolism, and interference with bacterial enzyme systems. Flavonoids like quercetin, catechins, and apigenin have shown potent activity against both Gram-positive and Gram-negative bacteria by targeting multiple cellular pathways simultaneously, which diminishes the likelihood of resistance development, flavonoids exhibit anti-inflammatory and antioxidant properties that can aid in mitigating infection-related tissue damage [20]. They also act as quorum sensing inhibitors, curbing bacterial virulence and biofilm formation. Flavonoids’ capability to synergize with antibiotics and other plant-based antimicrobials further enhances their therapeutic potential. Their natural abundance and relative safety profile encourage their incorporation into functional foods, nutraceuticals, and pharmaceutical formulations. Ongoing research focuses on enhancing their bioavailability and stability through advanced drug delivery systems, thereby broadening their application in clinical antimicrobial therapy.

9. Alkaloids in Disrupting Bacterial Metabolism and Structure
Alkaloids are nitrogen-containing natural compounds known for their potent pharmacological activities, including antimicrobial properties. Their antibacterial action often involves interference with DNA replication and transcription, disruption of membrane integrity, and inhibition of protein synthesis. Notable alkaloids like berberine, sanguinarine, and piperine have demonstrated effectiveness against various Gram-positive and Gram-negative pathogens by targeting critical bacterial processes. Alkaloids can integrate into bacterial cell membranes, causing destabilization, leakage of cell contents, and inhibition of key enzymes essential for bacterial survival, alkaloids exhibit the ability to modulate efflux pump activity, a major resistance mechanism in bacteria. By inhibiting these pumps, alkaloids increase the intracellular concentration of antimicrobial agents, enhancing their efficacy [21]. Some alkaloids also inhibit quorum sensing, thereby reducing bacterial virulence and biofilm development. The multifunctional nature of alkaloids not only makes them effective antimicrobial agents but also valuable components in combination therapies aimed at overcoming drug resistance. Their potential is further enhanced by ongoing studies exploring their pharmacokinetics and optimizing their delivery through novel formulation techniques.

10. Terpenoids and Their Membrane-Targeting Activity
Terpenoids, a large and diverse group of naturally occurring organic chemicals derived from isoprene units, are known for their strong antimicrobial effects, particularly against bacterial membranes. These lipophilic compounds can integrate into lipid bilayers, disrupting membrane structure and function. This disruption leads to increased permeability, loss of essential ions, and leakage of intracellular components, culminating in bacterial cell death [22]. Terpenoids like menthol, camphor, and limonene have shown efficacy against a wide array of bacterial pathogens by compromising membrane integrity and disrupting critical metabolic processes. Apart from direct antibacterial action, terpenoids exhibit strong anti-biofilm activity by interfering with bacterial adhesion and signaling pathways. They also display synergistic effects when combined with other antimicrobials, enhancing therapeutic outcomes against resistant strains. The hydrophobic nature of terpenoids poses formulation challenges, which have been addressed through encapsulation techniques such as nanoemulsions and liposomal delivery [23]. These advancements have significantly improved the solubility, stability, and bioavailability of terpenoids, paving the way for their integration into clinical and industrial antimicrobial applications.

11. Polyphenols in Combating Bacterial Virulence
Polyphenols, abundant in many plant sources, are known for their extensive antimicrobial and anti-inflammatory properties. They exert their antibacterial effects primarily by targeting bacterial enzymes, disrupting membrane integrity, and interfering with metabolic and signaling pathways. Polyphenols like resveratrol, epigallocatechin gallate, and gallic acid have been shown to inhibit bacterial growth by destabilizing cell membranes and impairing energy production processes. Their broad-spectrum activity includes effectiveness against antibiotic-resistant strains, making them valuable candidates in alternative antimicrobial therapies [24]. A significant aspect of polyphenols’ antibacterial action is their ability to attenuate bacterial virulence factors without necessarily killing the bacteria, thereby reducing the pressure for resistance development. They can inhibit the production of toxins, enzymes, and other factors essential for bacterial colonization and infection. Additionally, polyphenols have demonstrated anti-biofilm properties by disrupting bacterial adhesion and quorum sensing mechanisms. These attributes make them suitable for use in both preventive and therapeutic applications, particularly in managing chronic infections and enhancing the efficacy of existing antimicrobial agents.

12. Biofilm Inhibition by Plant-Based Compounds
Biofilms are structured communities of bacteria encased in a self-produced extracellular matrix, which protect bacteria from antibiotics and host immune responses. Plant-based compounds have shown remarkable potential in preventing biofilm formation and disrupting established biofilms. Phytochemicals like flavonoids, tannins, and essential oils can inhibit initial bacterial adhesion, disrupt matrix production, and interfere with quorum sensing signals essential for biofilm development. By targeting these processes, plant-based compounds enhance the susceptibility of biofilm-associated bacteria to antimicrobial agents [25]. The ability to inhibit biofilms is particularly valuable in medical device coatings, wound care, and chronic infection management, where biofilms pose significant treatment challenges, the use of plant-derived compounds in combination with antibiotics has been shown to enhance biofilm eradication and prevent recurrence. Research continues to explore the molecular mechanisms underlying biofilm inhibition by phytochemicals, with promising results indicating their potential as key components in anti-biofilm strategies across various industries, including healthcare, food processing, and water treatment.

13. Plant-Based Nanoparticles for Antimicrobial Delivery
The incorporation of plant-based compounds into nanoparticle delivery systems has emerged as an innovative strategy to enhance antimicrobial efficacy. Nanoparticles can improve the solubility, stability, and bioavailability of phytochemicals, enabling targeted delivery to infection sites and reducing systemic toxicity. Green synthesis of nanoparticles using plant extracts not only utilizes the reducing and stabilizing properties of phytochemicals but also imbues the nanoparticles with inherent antimicrobial activity [26]. These biogenic nanoparticles, often composed of metals like silver or zinc oxide, exhibit enhanced antibacterial properties due to their high surface area and unique physicochemical characteristics.

Nanoparticle-based delivery also facilitates penetration into bacterial biofilms, a major hurdle in effective antimicrobial therapy. Controlled release mechanisms offered by nanoparticle systems ensure sustained antibacterial action, which is critical for chronic infections. Moreover, the combination of plant-based antimicrobials with nanoparticle technology has shown promise in overcoming bacterial resistance mechanisms. The ongoing advancement in nanotechnology holds great potential for the clinical translation of plant-derived antimicrobials, offering a powerful tool in the fight against multidrug-resistant bacterial infections.

14. Impact of Synergy Between Phytochemicals and Antibiotics
The synergistic relationship between phytochemicals and antibiotics represents a crucial strategy in enhancing antimicrobial efficacy and combating resistance. When combined, plant-based compounds can potentiate the action of antibiotics by mechanisms such as inhibiting resistance enzymes, disrupting bacterial membranes, and enhancing antibiotic uptake [27]. This synergy has been observed in combinations like flavonoids with β-lactam antibiotics or essential oils with aminoglycosides, leading to restored sensitivity in resistant bacterial strains. Such interactions not only increase the effectiveness of treatment but also allow for lower antibiotic doses, reducing potential side effects and slowing resistance emergence.

The exploration of synergistic combinations extends beyond in vitro studies, with clinical research increasingly focusing on their therapeutic applications. The use of phytochemical-antibiotic combinations in treating persistent infections, particularly those involving biofilms or multidrug-resistant bacteria, has yielded promising results. These combinations can also broaden the spectrum of activity of existing antibiotics, making them effective against pathogens previously deemed untreatable. Continued investigation into the mechanisms and clinical efficacy of these synergistic interactions is essential for integrating them into standard antimicrobial protocols.

15. Future Perspectives in Plant-Based Antimicrobial Research
The future of plant-based antimicrobial research lies in the interdisciplinary integration of phytochemistry, microbiology, pharmacology, and nanotechnology. As antibiotic resistance continues to escalate, the need for alternative and complementary antimicrobial therapies becomes more urgent. Advances in analytical techniques, such as high-throughput screening and molecular docking, have accelerated the identification of promising phytochemicals with potent antimicrobial activity. Moreover, biotechnological approaches like genetic engineering of plants and microbial fermentation systems are being explored to enhance the production of valuable antimicrobial compounds, clinical translation of plant-based antimicrobials will require extensive pharmacokinetic and pharmacodynamic studies, as well as rigorous safety and efficacy trials. The development of standardized extraction protocols, quality control measures, and regulatory frameworks is essential to ensure the consistent therapeutic performance of plant-based products. Additionally, public awareness and acceptance of plant-based therapies will play a crucial role in their integration into mainstream healthcare. With sustained research efforts and technological advancements, plant-based antimicrobials hold great promise as effective, sustainable, and eco-friendly solutions in the global fight against bacterial pathogens and antimicrobial resistance.

Conclusion

Plant-based antimicrobial therapies represent a significant advancement in the ongoing battle against bacterial infections, especially in light of the global rise in antibiotic resistance. Unlike conventional antibiotics that often target a single bacterial function, phytochemicals derived from medicinal plants offer multi-targeted mechanisms of action, including membrane disruption, enzyme inhibition, interference with protein synthesis, and quorum sensing disruption. This versatility reduces the likelihood of bacteria developing resistance, making plant-based compounds effective both as standalone agents and as adjuncts to existing antibiotics. The broad-spectrum activity of these natural compounds against both Gram-positive and Gram-negative bacteria highlights their potential as a sustainable and powerful alternative to synthetic antimicrobial agents.

Technological advancements have further enhanced the potential of plant-derived antimicrobials by improving extraction methods and delivery systems. Modern techniques such as supercritical fluid extraction and ultrasonic-assisted extraction ensure higher purity and potency of phytochemicals, while nanotechnology-based delivery systems enhance bioavailability, stability, and targeted action. These innovations not only improve therapeutic outcomes but also minimize possible side effects by ensuring controlled release and site-specific activity. The synergy between plant-based compounds and conventional antibiotics has opened new avenues in combination therapies, offering promising results in overcoming multidrug-resistant infections, particularly those associated with biofilm formation and chronic bacterial persistence, the integration of plant-based antimicrobials into mainstream healthcare requires a concerted effort in research, clinical trials, and regulatory approvals. While the pharmacological potential of these natural compounds is evident, extensive studies on their pharmacokinetics, safety profiles, and efficacy in human subjects are essential for their successful application. Interdisciplinary collaboration among botanists, microbiologists, pharmacologists, and healthcare professionals will be critical in harnessing the full potential of plant-based antimicrobial agents. With continued scientific exploration and technological innovation, plant-based antimicrobial therapies hold immense promise as a key component in the global strategy to manage and combat infectious diseases in a sustainable and eco-friendly manner.

References

• AlSheikh, H. M. A., Sultan, I., Kumar, V., Rather, I. A., Al-Sheikh, H., Tasleem Jan, A., & Haq, Q. M. R. (2020). Plant-based phytochemicals as possible alternative to antibiotics in combating bacterial drug resistance. Antibiotics, 9(8), 480.
• Arip, M., Selvaraja, M., R, M., Tan, L. F., Leong, M. Y., Tan, P. L., & Jubair, N. (2022). Review on plant-based management in combating antimicrobial resistance-mechanistic perspective. Frontiers in Pharmacology, 13, 879495.
• Abolarinwa, T. O., Ajose, D. J., Oluwarinde, B. O., Fri, J., Montso, K. P., Fayemi, O. E., & Ateba, C. N. (2022). Plant-derived nanoparticles as alternative therapy against Diarrheal pathogens in the era of antimicrobial resistance: A review. Frontiers in Microbiology, 13, 1007115.
• Chandra, H., Bishnoi, P., Yadav, A., Patni, B., Mishra, A. P., & Nautiyal, A. R. (2017). Antimicrobial resistance and the alternative resources with special emphasis on plant-based antimicrobials—a review. Plants, 6(2), 16.
• Shriram, V., Khare, T., Bhagwat, R., Shukla, R., & Kumar, V. (2018). Inhibiting bacterial drug efflux pumps via phyto-therapeutics to combat threatening antimicrobial resistance. Frontiers in microbiology, 9, 2990.
• Mayegowda, S. B., Ng, M., Alghamdi, S., Atwah, B., Alhindi, Z., & Islam, F. (2022). Role of antimicrobial drug in the development of potential therapeutics. Evidence‐Based Complementary and Alternative Medicine, 2022(1), 2500613.
• Keita, K., Darkoh, C., & Okafor, F. (2022). Secondary plant metabolites as potent drug candidates against antimicrobial-resistant pathogens. SN Applied Sciences, 4(8), 209.
• Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., … & van Dongen, M. B. (2022). Progress in alternative strategies to combat antimicrobial resistance: focus on antibiotics. Antibiotics, 11(2), 200.
• Nguyen, N. T. T., Nguyen, L. M., Nguyen, T. T. T., Nguyen, T. T., Nguyen, D. T. C., & Tran, T. V. (2022). Formation, antimicrobial activity, and biomedical performance of plant-based nanoparticles: a review. Environmental Chemistry Letters, 20(4), 2531-2571.
• Cheesman, M. J., Ilanko, A., Blonk, B., & Cock, I. E. (2017). Developing new antimicrobial therapies: are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution?. Pharmacognosy reviews, 11(22), 57.
• Subramani, R., Narayanasamy, M., & Feussner, K. D. (2017). Plant-derived antimicrobials to fight against multi-drug-resistant human pathogens. 3 Biotech, 7(3), 172.
• Vaou, N., Stavropoulou, E., Voidarou, C., Tsigalou, C., & Bezirtzoglou, E. (2021). Towards advances in medicinal plant antimicrobial activity: A review study on challenges and future perspectives. Microorganisms, 9(10), 2041.
• Hano, C., & Abbasi, B. H. (2021). Plant-based green synthesis of nanoparticles: Production, characterization and applications. Biomolecules, 12(1), 31.
• Nortjie, E., Basitere, M., Moyo, D., & Nyamukamba, P. (2022). Extraction methods, quantitative and qualitative phytochemical screening of medicinal plants for antimicrobial textiles: a review. Plants, 11(15), 2011.
• Tache, A. M., Dinu, L. D., & Vamanu, E. (2022). Novel insights on plant extracts to prevent and treat recurrent urinary tract infections. Applied Sciences, 12(5), 2635.
• Marquardt, R. R., & Li, S. (2018). Antimicrobial resistance in livestock: advances and alternatives to antibiotics. Animal Frontiers, 8(2), 30-37.
• Kopel, J., McDonald, J., & Hamood, A. (2022). An assessment of the in vitro models and clinical trials related to the antimicrobial activities of phytochemicals. Antibiotics, 11(12), 1838.
• Parmanik, A., Das, S., Kar, B., Bose, A., Dwivedi, G. R., & Pandey, M. M. (2022). Current treatment strategies against multidrug-resistant bacteria: a review. Current microbiology, 79(12), 388.
• Lin, S., Li, H., Tao, Y., Liu, J., Yuan, W., Chen, Y., … & Liu, S. (2020). In vitro and in vivo evaluation of membrane-active flavone amphiphiles: semisynthetic kaempferol-derived antimicrobials against drug-resistant gram-positive bacteria. Journal of Medicinal Chemistry, 63(11), 5797-5815.
• Mulat, M., Pandita, A., & Khan, F. (2019). Medicinal plant compounds for combating the multi-drug resistant pathogenic bacteria: a review. Current pharmaceutical biotechnology, 20(3), 183-196.
• Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A. R. (2018). Nano-strategies to fight multidrug resistant bacteria—“A Battle of the Titans”. Frontiers in microbiology, 9, 1441.
• Bhattacharya, S., Gupta, D., Sen, D., & Bhattacharjee, C. (2020). Development of micellized antimicrobial thiosulfinate: a contemporary way of drug stability enhancement. In Advances in Bioprocess Engineering and Technology: Select Proceedings ICABET 2020 (pp. 83-89). Singapore: Springer Singapore.
• Ranjani, S., Priya, P. S., Veerasami, M., & Hemalatha, S. (2022). Novel polyherbal nanocolloids to control bovine mastitis. Applied biochemistry and biotechnology, 194(1), 246-265.
• Ajose, D. J., Abolarinwa, T. O., Oluwarinde, B. O., Montso, P. K., Fayemi, O. E., Aremu, A. O., & Ateba, C. N. (2022). Application of plant-derived nanoparticles (PDNP) in food-producing animals as a bio-control agent against antimicrobial-resistant pathogens. Biomedicines, 10(10), 2426.
• Alam, M., Bano, N., Ahmad, T., Sharangi, A. B., Upadhyay, T. K., Alraey, Y., … & Saeed, M. (2022). Synergistic role of plant extracts and essential oils against multidrug resistance and gram-negative bacterial strains producing extended-spectrum β-lactamases. Antibiotics, 11(7), 855.
• Srivastava, S., Dashora, K., Ameta, K. L., Singh, N. P., El‐Enshasy, H. A., Pagano, M. C., … & Bhargava, A. (2021). Cysteine‐rich antimicrobial peptides from plants: The future of antimicrobial therapy. Phytotherapy Research, 35(1), 256-277.
• Mahavy, C. E., Duez, P., ElJaziri, M., & Rasamiravaka, T. (2020). African plant-based natural products with antivirulence activities to the rescue of antibiotics. Antibiotics, 9(11), 830.